Approval · Notice of Compliance 6142 · 2002
AERRANE: Notice of Compliance 6142
Issued January 14, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6142
- Date
- January 14, 2002
- Company
- Baxter CorporationMississauga, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Anaesthetic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AERRANE | 02225875 | Marketed |
Medicinal ingredients
- ISOFLURANE 99.9 PER